- Home
- » Tags
- » Neonatal Fc receptor
Top View
- How Functional Foods Play Critical Roles in Human Health
- Engineering the Interactions Between a Plant-Produced HIV Antibody And
- A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
- Fc Receptors: Regulatory Mechanisms and Function in Antibody Therapy
- MHC Class I-Related Neonatal Fc Receptor for Igg Is Functionally
- Antibody Structure and Function: the Basis for Engineering Therapeutics
- Diverse Homeostatic and Immunomodulatory Roles of Immune
- Role of Polymeric Immunoglobulin Receptor in Iga and Igm Transcytosis
- Fcrn) Monoclonal Antibody
- 1 the Immune System M
- Product Data Sheet Anti-Human Fc Receptor (Fcrn) Monoclonal Antibody
- Regulation of the Actin Cytoskeleton in Podocytes
- Distribution of the Igg Fc Receptor, Fcrn, in the Human Fetal Intestine
- Fragments Antigen Delivery Using Engineered Fc Targeting The
- Fc Effector Functions Binding to the Neonatal Fc Receptor Affects Fc
- Expression of the Neonatal Fc-Receptor in Placental-Fetal Endothelium and in Cells of the Placental Immune System T
- Dynamics and Cargo Selectivity of Endocytic Adaptor Proteins by Peter
- I-Related Neonatal Fc Receptor for Igg Functional Expression of the MHC Class Can Down-Regulate Γ Pathway By
- Aglycosylated Igg Variants Expressed in Bacteria That Selectively Bind Fcγri Potentiate Tumor Cell Killing by Monocyte-Dendritic Cells
- Neonatal Fc Receptor Promotes Immune Complex– Mediated Glomerular Disease
- Neonatal Fc Receptor Mediates Internalization of Fc in Transfected Human Endothelial Cells Nancy A
- Human Neonatal Fc Receptor Mediates Transport of Igg Into Luminal Secretions for Delivery of Antigens to Mucosal Dendritic Cells
- Boosting Therapeutic Potency of Antibodies by Taming Fc Domain Functions Tae Hyun Kang1 and Sang Taek Jung2
- WO 2014/001324 Al 3 January 2014 (03.01.2014) P O P C T
- Effects of Receptor Dimerization on the Interaction Between the Class I
- Fcrnfcrnfcrnfcrnf
- Podocyte-Specific Knockout of the Neonatal Fc Receptor (Fcrn) Results In
- View Abstract Supplement (PDF)
- Reduced Fcrn-Mediated Transcytosis of Igg2 Due to a Missing Glycine in Its Lower Hinge Received: 19 February 2018 Nigel M
- Ncounter® Mouse Immunology Panel
- Idiopathic Nephrotic Syndrome: the EBV Hypothesis
- Transepithelial Transport of Nanoparticles Targeted to the Neonatal Fc Receptor for Oral Delivery Applications Hi 2 6, 2013
- Fcrn Antagonists in ITP
- Understanding the Role for Fc Gamma Receptors in Response to Anti-CD20 Monoclonal Antibody Therapy
- Rotavirus Vaccines and Impact of Maternal
- Fc-Receptor Targeted Therapies for the Treatment of Myasthenia Gravis
- Fc Receptor Testing – a Useful Tool for Assessment of Monoclonal Antibodies
- Localization of Neonatal Fc Receptor for Igg in Aggregated Lymphoid Nodules Area in Abomasum of Bactrian Camels
- (12) United States Patent (10) Patent No.: US 8,969,526 B2 Baehner Et Al
- WO 2013/049254 Al 4 April 2013 (04.04.20 13 ) W P O P C T
- Fcrn Across the Therapeutic Spectrum
- Fc Fusion As a Platform Technology: Potential for Modulating Immunogenicity
- Welcome to the FIT Board Review Corner, Prepared by Timothy Chow, MD, and Christopher Foster, MD, Senior and Junior Representati
- Fc RECEPTORS and THEIR INTERACTIONS with IMMUNOGLOBULINS
- Immunobiology of Congenital Cytomegalovirus Infection of the Central Nervous System—The Murine Cytomegalovirus Model